$ACT Company News Second 2% S&P 500 spike sign
Post# of 74540
Posted On: 12/22/2014 12:16:40 PM
$ACT Company News
Second 2% S&P 500 spike signals strong bull trend 11:23 a.m. Dec. 19, 2014 - Michael Ashbaugh
Here are the best S&P 500 stocks and sectors of 2014 7:15 a.m. Dec. 19, 2014 - Philip van Doorn
What a week: Botox haze, merger Monday and The Tanned One 9:19 a.m. Nov. 21, 2014 - Marek Fuchs
Valeant's stock rises after new $2 billion buyback plan announced 12:00 p.m. Nov. 20, 2014 - Tomi Kilgore
La-Z-Boy shares rally after earnings beat targets 4:41 p.m. Nov. 18, 2014 - Sue Chang
S&P, Dow ring up records Tuesday 4:35 p.m. Nov. 18, 2014 - Barbara Kollmeyer
Actavis shares outpace buyout target’s gains 12:30 p.m. Nov. 18, 2014 - Russ Britt
S&P 500 registers 42nd record close in skittish market 4:59 p.m. Nov. 17, 2014 - Carla Mozee
Urban Outfitters slides after earnings miss expectations 4:43 p.m. Nov. 17, 2014 - Sue Chang
Valeant says it won’t meet Actavis’s offer 12:18 p.m. Nov. 17, 2014 - Russ Britt
If you're looking big pharma, look no further than Actavis 11:33 a.m. Nov. 17, 2014 - The Trading Deck
Actavis to buy Allergan in $66 billion deal 9:35 a.m. Nov. 17, 2014 - Jonathan D. Rockoff
Actavis confirms to buy Allergan in $66 billion deal 9:30 a.m. Nov. 17, 2014 - Ciara Linnane
Actavis, Allergan close to a deal 8:33 a.m. Nov. 17, 2014 - Jonathan D. Rockoff
Allergan, Actavis near cash-and-stock deal: WSJ 1:48 p.m. Nov. 16, 2014 - Andria Cheng
10 S&P 500 companies with the fastest revenue growth 8:28 a.m. Nov. 11, 2014 - Philip van Doorn
Ackman urges Allergan to open sale process, negotiate 10:33 a.m. Nov. 7, 2014 - Chelsey Dulaney
Actavis sales surge, exceed forecasts 7:51 a.m. Nov. 5, 2014 - MarketWatch.com
Media, consumer-based company earnings to test stock rally 4:30 a.m. Nov. 2, 2014 - Wallace Witkowski
Pfizer sales fall less than expected 7:34 a.m. Oct. 28, 2014 - MarketWatch.com
Actavis 8-K Shows $1B Revolving Credit Facility Replacing Existing $750M Pact; Term Loan Credit Pact In 2 Tranches Of $2.75B Each 5:43 a.m. Today - benzinga.com
10 Biggest Mergers and Acquisitions of 2014 3:15 a.m. Today - InvestorPlace.com
Merrill Lynch Top Healthcare Stock Picks for 2015 2:00 p.m. Dec. 19, 2014 - 247WallSt.com
Doug Loe: Canada Has Earned Its Spot In The Biotech All-Star Team Photo 10:53 a.m. Dec. 19, 2014 - Seeking Alpha
Baidu, Alibaba Among Top World Stocks Building Bases 5:09 p.m. Dec. 18, 2014 - Investors Business Daily
Emergent BioSolutions Buys EV-035 Series from Evolva - Analyst Blog 4:45 p.m. Dec. 18, 2014 - Zacks.com
9 Big Stocks That Doubled in 2014 11:19 a.m. Dec. 18, 2014 - 247WallSt.com
Tetraphase Jumps As 'Superbug' Drug Scores In Trial 10:54 a.m. Dec. 18, 2014 - Investors Business Daily
Cyclacel Falls on Poor Acute Myeloid Leukemia Drug Data - Analyst Blog 5:00 p.m. Dec. 17, 2014 - Zacks.com
Alexion Announces New Share Repurchase Program of $500M - Analyst Blog 6:55 p.m. Dec. 16, 2014 - Zacks.com
Actavis to Appeal Ruling Regarding Namenda IR Sales - Analyst Blog 6:20 p.m. Dec. 16, 2014 - Zacks.com
Great Stocks: Valeant Pharmaceuticals Near Buy Point 5:11 p.m. Dec. 16, 2014 - Investors Business Daily
Sophiris Plunges on Disappointing Data on its BPH Candidate - Analyst Blog 4:30 p.m. Dec. 16, 2014 - Zacks.com
Actavis Unveils Management Changes 10:28 a.m. Dec. 16, 2014 - The Wall Street Journal Interactive Edition
Pharma Deal’s Victor Now Must Execute 10:05 a.m. Dec. 16, 2014 - The Wall Street Journal Interactive Edition
Actavis unveils post-Allergan management structure 9:33 a.m. Dec. 16, 2014 - Seeking Alpha
ChemoCentryx Up on Positive Diabetic Nephropathy Data - Analyst Blog 6:45 p.m. Dec. 15, 2014 - Zacks.com
Buffett and Billionaire Investors Look to Oil, Health Care and Spinoffs in 2015 9:27 a.m. Dec. 15, 2014 - TheStreet.com
5 “Best of the Best” Stocks for 2015 5:11 a.m. Dec. 15, 2014 - InvestorPlace.com
What Investors Can Learn From The Portfolios Of Fund Managers 5:47 a.m. Dec. 14, 2014 - Seeking Alpha
Actavis Names Jonathon Kellerman Executive Vice President, Global Chief Compliance Officer 9:24 a.m. Today - PR Newswire - PRF
Actavis to Present at 33rd Annual J.P. Morgan Healthcare Conference 9:00 a.m. Today - PR Newswire - PRF
XYDALBA™ (dalbavancin) Receives CHMP Positive Opinion for the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in Adults 4:15 p.m. Dec. 19, 2014 - PR Newswire - PRF
Actavis to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference 9:00 a.m. Dec. 19, 2014 - PR Newswire - PRF
Actavis Announces Proposed Senior Leadership Team Effective Following Completion of Allergan Acquisition 7:30 a.m. Dec. 16, 2014 - PR Newswire - PRF
Actavis Will Appeal Injunction Requiring Continued Distribution of NAMENDA® IR 3:11 p.m. Dec. 15, 2014 - PR Newswire - PRF
Actavis Launches Generic Version of Celebrex® 9:28 a.m. Dec. 10, 2014 - PR Newswire - PRF
Anti-Infective Advisory Committee Recommends Approval Of Actavis' Ceftazidime-Avibactam 4:46 p.m. Dec. 5, 2014 - PR Newswire - PRF
No Wrinkles in Actavis' $66 Billion Deal to Buy Botox Maker Allergan, an Industrial Info News Alert 6:15 a.m. Dec. 3, 2014 - Marketwired
Stock Updates on Pharma Services - Avanir Pharma, Zoetis, Allergan, Mallinckrodt, and Actavis 8:30 a.m. Nov. 25, 2014 - PR Newswire - PRF
Critical Alerts For Gold Fields, Actavis, Trina Solar Limited, Alcoa and Herbalife Released By InvestorsObserver 9:31 a.m. Nov. 19, 2014 - PR Newswire - PRF
ALLERGAN, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 10:32 a.m. Nov. 17, 2014 - PR Newswire - PRF
Valeant Comments On Allergan Announcement 9:29 a.m. Nov. 17, 2014 - PR Newswire - PRF
Actavis to Acquire Allergan to Create Top 10 Global Growth Pharmaceutical Company with $23 Billion in Revenue 9:15 a.m. Nov. 17, 2014 - PR Newswire - PRF
Actavis Successfully Completes Durata Therapeutics, Inc. Tender Offer 8:00 a.m. Nov. 17, 2014 - PR Newswire - PRF
Actavis Announces FDA Acceptance of sNDA for SAPHRIS® (asenapine) for the Treatment of Bipolar I Disorder in Pediatric Patients 8:00 a.m. Nov. 13, 2014 - PR Newswire - PRF
Actavis Names Maria Teresa Hilado Chief Financial Officer 4:15 p.m. Nov. 10, 2014 - PR Newswire - PRF
Quarterly Financial Performance Reviews, Upcoming Events, and Medicare Plan Launch - Research Reports on Actavis, Celgene, UnitedHealth, Jazz and Endo 8:50 a.m. Nov. 10, 2014 - PR Newswire - PRF
Actavis Announces Planned Retirement of R. Todd Joyce in Early 2015 6:45 a.m. Nov. 5, 2014 - PR Newswire - PRF
Actavis Net Revenue Increases 83% to $3.7 Billion in Third Quarter 2014; Non-GAAP EPS Increases 53% to $3.19 6:30 a.m. Nov. 5, 2014 - PR Newswire - PRF
Second 2% S&P 500 spike signals strong bull trend 11:23 a.m. Dec. 19, 2014 - Michael Ashbaugh
Here are the best S&P 500 stocks and sectors of 2014 7:15 a.m. Dec. 19, 2014 - Philip van Doorn
What a week: Botox haze, merger Monday and The Tanned One 9:19 a.m. Nov. 21, 2014 - Marek Fuchs
Valeant's stock rises after new $2 billion buyback plan announced 12:00 p.m. Nov. 20, 2014 - Tomi Kilgore
La-Z-Boy shares rally after earnings beat targets 4:41 p.m. Nov. 18, 2014 - Sue Chang
S&P, Dow ring up records Tuesday 4:35 p.m. Nov. 18, 2014 - Barbara Kollmeyer
Actavis shares outpace buyout target’s gains 12:30 p.m. Nov. 18, 2014 - Russ Britt
S&P 500 registers 42nd record close in skittish market 4:59 p.m. Nov. 17, 2014 - Carla Mozee
Urban Outfitters slides after earnings miss expectations 4:43 p.m. Nov. 17, 2014 - Sue Chang
Valeant says it won’t meet Actavis’s offer 12:18 p.m. Nov. 17, 2014 - Russ Britt
If you're looking big pharma, look no further than Actavis 11:33 a.m. Nov. 17, 2014 - The Trading Deck
Actavis to buy Allergan in $66 billion deal 9:35 a.m. Nov. 17, 2014 - Jonathan D. Rockoff
Actavis confirms to buy Allergan in $66 billion deal 9:30 a.m. Nov. 17, 2014 - Ciara Linnane
Actavis, Allergan close to a deal 8:33 a.m. Nov. 17, 2014 - Jonathan D. Rockoff
Allergan, Actavis near cash-and-stock deal: WSJ 1:48 p.m. Nov. 16, 2014 - Andria Cheng
10 S&P 500 companies with the fastest revenue growth 8:28 a.m. Nov. 11, 2014 - Philip van Doorn
Ackman urges Allergan to open sale process, negotiate 10:33 a.m. Nov. 7, 2014 - Chelsey Dulaney
Actavis sales surge, exceed forecasts 7:51 a.m. Nov. 5, 2014 - MarketWatch.com
Media, consumer-based company earnings to test stock rally 4:30 a.m. Nov. 2, 2014 - Wallace Witkowski
Pfizer sales fall less than expected 7:34 a.m. Oct. 28, 2014 - MarketWatch.com
Actavis 8-K Shows $1B Revolving Credit Facility Replacing Existing $750M Pact; Term Loan Credit Pact In 2 Tranches Of $2.75B Each 5:43 a.m. Today - benzinga.com
10 Biggest Mergers and Acquisitions of 2014 3:15 a.m. Today - InvestorPlace.com
Merrill Lynch Top Healthcare Stock Picks for 2015 2:00 p.m. Dec. 19, 2014 - 247WallSt.com
Doug Loe: Canada Has Earned Its Spot In The Biotech All-Star Team Photo 10:53 a.m. Dec. 19, 2014 - Seeking Alpha
Baidu, Alibaba Among Top World Stocks Building Bases 5:09 p.m. Dec. 18, 2014 - Investors Business Daily
Emergent BioSolutions Buys EV-035 Series from Evolva - Analyst Blog 4:45 p.m. Dec. 18, 2014 - Zacks.com
9 Big Stocks That Doubled in 2014 11:19 a.m. Dec. 18, 2014 - 247WallSt.com
Tetraphase Jumps As 'Superbug' Drug Scores In Trial 10:54 a.m. Dec. 18, 2014 - Investors Business Daily
Cyclacel Falls on Poor Acute Myeloid Leukemia Drug Data - Analyst Blog 5:00 p.m. Dec. 17, 2014 - Zacks.com
Alexion Announces New Share Repurchase Program of $500M - Analyst Blog 6:55 p.m. Dec. 16, 2014 - Zacks.com
Actavis to Appeal Ruling Regarding Namenda IR Sales - Analyst Blog 6:20 p.m. Dec. 16, 2014 - Zacks.com
Great Stocks: Valeant Pharmaceuticals Near Buy Point 5:11 p.m. Dec. 16, 2014 - Investors Business Daily
Sophiris Plunges on Disappointing Data on its BPH Candidate - Analyst Blog 4:30 p.m. Dec. 16, 2014 - Zacks.com
Actavis Unveils Management Changes 10:28 a.m. Dec. 16, 2014 - The Wall Street Journal Interactive Edition
Pharma Deal’s Victor Now Must Execute 10:05 a.m. Dec. 16, 2014 - The Wall Street Journal Interactive Edition
Actavis unveils post-Allergan management structure 9:33 a.m. Dec. 16, 2014 - Seeking Alpha
ChemoCentryx Up on Positive Diabetic Nephropathy Data - Analyst Blog 6:45 p.m. Dec. 15, 2014 - Zacks.com
Buffett and Billionaire Investors Look to Oil, Health Care and Spinoffs in 2015 9:27 a.m. Dec. 15, 2014 - TheStreet.com
5 “Best of the Best” Stocks for 2015 5:11 a.m. Dec. 15, 2014 - InvestorPlace.com
What Investors Can Learn From The Portfolios Of Fund Managers 5:47 a.m. Dec. 14, 2014 - Seeking Alpha
Actavis Names Jonathon Kellerman Executive Vice President, Global Chief Compliance Officer 9:24 a.m. Today - PR Newswire - PRF
Actavis to Present at 33rd Annual J.P. Morgan Healthcare Conference 9:00 a.m. Today - PR Newswire - PRF
XYDALBA™ (dalbavancin) Receives CHMP Positive Opinion for the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in Adults 4:15 p.m. Dec. 19, 2014 - PR Newswire - PRF
Actavis to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference 9:00 a.m. Dec. 19, 2014 - PR Newswire - PRF
Actavis Announces Proposed Senior Leadership Team Effective Following Completion of Allergan Acquisition 7:30 a.m. Dec. 16, 2014 - PR Newswire - PRF
Actavis Will Appeal Injunction Requiring Continued Distribution of NAMENDA® IR 3:11 p.m. Dec. 15, 2014 - PR Newswire - PRF
Actavis Launches Generic Version of Celebrex® 9:28 a.m. Dec. 10, 2014 - PR Newswire - PRF
Anti-Infective Advisory Committee Recommends Approval Of Actavis' Ceftazidime-Avibactam 4:46 p.m. Dec. 5, 2014 - PR Newswire - PRF
No Wrinkles in Actavis' $66 Billion Deal to Buy Botox Maker Allergan, an Industrial Info News Alert 6:15 a.m. Dec. 3, 2014 - Marketwired
Stock Updates on Pharma Services - Avanir Pharma, Zoetis, Allergan, Mallinckrodt, and Actavis 8:30 a.m. Nov. 25, 2014 - PR Newswire - PRF
Critical Alerts For Gold Fields, Actavis, Trina Solar Limited, Alcoa and Herbalife Released By InvestorsObserver 9:31 a.m. Nov. 19, 2014 - PR Newswire - PRF
ALLERGAN, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 10:32 a.m. Nov. 17, 2014 - PR Newswire - PRF
Valeant Comments On Allergan Announcement 9:29 a.m. Nov. 17, 2014 - PR Newswire - PRF
Actavis to Acquire Allergan to Create Top 10 Global Growth Pharmaceutical Company with $23 Billion in Revenue 9:15 a.m. Nov. 17, 2014 - PR Newswire - PRF
Actavis Successfully Completes Durata Therapeutics, Inc. Tender Offer 8:00 a.m. Nov. 17, 2014 - PR Newswire - PRF
Actavis Announces FDA Acceptance of sNDA for SAPHRIS® (asenapine) for the Treatment of Bipolar I Disorder in Pediatric Patients 8:00 a.m. Nov. 13, 2014 - PR Newswire - PRF
Actavis Names Maria Teresa Hilado Chief Financial Officer 4:15 p.m. Nov. 10, 2014 - PR Newswire - PRF
Quarterly Financial Performance Reviews, Upcoming Events, and Medicare Plan Launch - Research Reports on Actavis, Celgene, UnitedHealth, Jazz and Endo 8:50 a.m. Nov. 10, 2014 - PR Newswire - PRF
Actavis Announces Planned Retirement of R. Todd Joyce in Early 2015 6:45 a.m. Nov. 5, 2014 - PR Newswire - PRF
Actavis Net Revenue Increases 83% to $3.7 Billion in Third Quarter 2014; Non-GAAP EPS Increases 53% to $3.19 6:30 a.m. Nov. 5, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼